BusinessNewLink Genetics Receives Notice of Allowance from USPTO Covering Indoximod Salts and ProdrugsBy Nasdaq OMXJul 10, 2017, 11:00 AM UTC
BusinessNewLink Genetics to Host Its Second Quarter 2017 Financial Results Conference Call on July 28, 2017By Nasdaq OMXJul 7, 2017, 11:00 AM UTC
BusinessNew Study with Abiomed’s Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary ArteryBy Nasdaq OMXJun 30, 2017, 12:04 PM UTC
BusinessEarth Science Tech, Inc. Receives a Price Target of $4.12 from Leading Independent Equity Research & Corporate Firm, SeeThruEquityBy Nasdaq OMXJun 29, 2017, 12:45 PM UTC
BusinessLice Clinics of America Announces Equity Crowdfunding CampaignBy Nasdaq OMXJun 28, 2017, 12:00 PM UTC
BusinessNovel Findings Obtained with the PURE EP System to be Presented at American Heart Association’s BCVS Scientific Sessions 2017By Nasdaq OMXJun 26, 2017, 12:00 PM UTC
BusinessPositive Phase 1b Data for NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, in Combination with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Presented at the European Hematologic Association (EHA) Congress in Madrid, SpaiBy Nasdaq OMXJun 23, 2017, 11:00 AM UTC
BusinessWalter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of DepressionBy Nasdaq OMXJun 22, 2017, 9:12 PM UTC
